HSE - PCRS

Application Details

HSE Application ID

HSE100100

HTA Number

26015

HTA Link

https://www.ncpe.ie/faricimab-vabysmo-hta-id-26015/

Drug

faricimab

Brand

Vabysmo®

Applicant

Roche

Indication Applied For

Indicated for the treatment of adult patients with visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO).

Application Date

30/03/2026

Marketing Authorisation Date

26/07/2024

Application Status

Awaiting Proposal from Applicant

25/06/2026

Applicant Meeting Held with CPU

25/06/2026

Proposal from Applicant Under Review

14/05/2026

Awaiting Proposal from Applicant

13/05/2026

Rapid Review Completed

07/05/2026

Rapid Review Commissioned

30/03/2026

Pricing and Reimbursement Application Complete

30/03/2026

New Search